Naomi M. Fuller
-
- Antibiotic Use and Resistance 2
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 3
-
- COVID-19 epidemiological studies 1
-
- Tuberculosis Research and Epidemiology 1
-
- Evolution and Genetic Dynamics 1
-
- Pneumonia and Respiratory Infections 1
- Co-authors
- Christopher Finn McQuaidGwenan M. KnightKarin GallandatQuentin J. LeclercRumina HasanSam WillcocksEsther van KleefR. E. Glover
- Partner nations
- United KingdomSwitzerlandZimbabwe
In The Last Decade
Naomi M. Fuller
3 papers receiving 244 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Applied Microbiology and Biotechnology 134
- Molecular Medicine 81
- Clinical Biochemistry 28
- Critical Care and Intensive Care Medicine 17
- Modeling and Simulation 15
Countries citing papers authored by Naomi M. Fuller
This map shows the geographic impact of Naomi M. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi M. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi M. Fuller more than expected).
Fields of papers citing papers by Naomi M. Fuller
This network shows the impact of papers produced by Naomi M. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi M. Fuller. The network helps show where Naomi M. Fuller may publish in the future.
Co-authorship network
The 20 scholars most cited alongside Naomi M. Fuller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 5 | |
| 3 | Antimicrobial resistance and COVID-19: Intersections and implicationsbreakdown → | 2021 | 240 |
About Naomi M. Fuller
Naomi M. Fuller is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Modeling and Simulation, having authored 3 papers that have together received 250 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (3 papers), Antibiotic Use and Resistance (2 papers), COVID-19 epidemiological studies (1 paper), Tuberculosis Research and Epidemiology (1 paper), Evolution and Genetic Dynamics (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (134 citations), Molecular Medicine (81 citations) and Clinical Biochemistry (28 citations). Naomi M. Fuller has collaborated with scholars based in United Kingdom, Switzerland and Zimbabwe. Frequent co-authors include Christopher Finn McQuaid, Gwenan M. Knight, Karin Gallandat, Quentin J. Leclerc, Rumina Hasan, Sam Willcocks, Esther van Kleef, R. E. Glover, Ioana D. Olaru and Clare Chandler. Their work appears in journals such as PLoS Pathogens, eLife and BMJ Global Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.